2014. ECRD Conference – Patient-reported outcomes (PRO) claims in products indicated for the treatment of rare diseases and approved by the European Medicines Agency (EMA)

Arnould B, Perrier LL, Acquadro C. Patient-reported outcomes (PRO) claims in products indicated for the treatment of rare diseases and approved by the European Medicines Agency (EMA). Presented at: 7th European Conference on Rare Diseases and Orphan Products (ECRD); May 8, 2014; Berlin, Germany.